CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 111 filers reported holding CLOVIS ONCOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $200,000 | -68.6% | 28,584 | -71.4% | 0.02% | -75.4% |
Q1 2020 | $636,000 | -91.3% | 100,054 | +28.6% | 0.07% | -37.3% |
Q2 2017 | $7,284,000 | +1256.4% | 77,800 | +177.9% | 0.11% | +323.1% |
Q1 2016 | $537,000 | -90.6% | 28,000 | -55.1% | 0.03% | -94.0% |
Q3 2015 | $5,738,000 | +2484.7% | 62,400 | +1980.0% | 0.43% | +1957.1% |
Q1 2015 | $222,000 | -40.6% | 3,000 | -44.4% | 0.02% | +16.7% |
Q1 2014 | $374,000 | +68.5% | 5,400 | +45.9% | 0.02% | -14.3% |
Q4 2013 | $222,000 | – | 3,700 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |